Clinical trials: Intrauterine Devices
Pain
Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD).
The aim of this study is to determine the effectiveness of a combination of diclofenac and lidocaine gel in reducing pain during IUD insertion.
- Trial name
- NCT02332057
- Testing
- Diclofenac plus lidocaine
- Where
- Egypt
- Volunteers
- 90 people
- Sponsor
- Cairo University
Contraception
Comparison Between Intrauterine Contraceptive Device Insertion During Cesarean Section Vs Conventional Application
The study aims to compare immediate post-placental (within 10 minutes of placenta delivery) intrauterine contraceptive device (Copper T 380A) insertion versus conventional placement at 6 weeks (often referred to as delayed or…
- Trial name
- NCT02674139
- Testing
- Copper T 380A IUD
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- sara AbdAllah
Intrauterine Device
Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery
To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces failed insertions, insertion-related complications, and pain in Women With no Previous…
- Trial name
- NCT04045548
- Testing
- Dinoprostone
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Cairo University
Scar Niche, Myometrial Remodeling
Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
The purpose of the study is to determine whether immediate postplacental copper T380A intrauterine device insertion increases uterine-niche incidence compared with postpartum progestin-only pills after primary cesarean section .
- Conditions
- Scar Niche, Myometrial Remodeling, Contraceptive Device; Complications, Cesarean Section Complications
- Trial name
- T380A (NCT07264933)
- Testing
- Primary Cesarean Section, immediate postplacental insertion of a copper T380A intrauterine device, progesterone-only pills
- Where
- Egypt
- Volunteers
- 750 people
- Sponsor
- Benha University
Pain
Topical Lidocaine for Pain Control With Intrauterine Device (IUD) Insertion
Intrauterine contraception is a very effective, long term, reversible form of birth control, and is increasingly used in young, nulliparous patients.
- Trial name
- NCT01445756
- Testing
- Lidocaine
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Nulliparous
Scandinavian Mirena Insertion Nulliparous Trial.
In this non-interventional study we investigate the nulliparous women individual evaluation of the insertion procedure of LNG-IUD and the follow-up period of 3 months post insertion.
- Trial name
- NCT00798980
- Testing
- Mirena (BAY86-5028)
- Where
- Sweden
- Volunteers
- 224 people, healthy volunteers welcome
- Sponsor
- Bayer
"Lost" IUD
Anesthetic Efficacy of Intrauterine Lidocaine for Removal of a "Lost" Intrauterine Device
Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a "lost" intrauterine device (IUD).
- Trial name
- NCT00308841
- Testing
- Lidocaine (drug)
- Where
- Turkey (Türkiye)
- Sponsor
- Suleyman Demirel University
Contraception
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare…
- Trial name
- NCT03657602
- Testing
- Kyleena Intrauterine System, Mirena Intrauterine System
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Women at Risk for Pregnancy
A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)
to Assess the Pharmacokinetic Properties of VeraCept® Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women
- Trial name
- IUD (NCT03785366)
- Testing
- VeraCept, ParaGard
- Where
- 2 sites in United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Sebela Women's Health Inc.
Contraception, IUD
Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure.
- Conditions
- Contraception, IUD, Anesthesia, Local
- Trial name
- NCT05252117
- Testing
- Articaine Hydrochloride 40 MG/ML, Mepivacaine
- Where
- Brazil
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Universidade do Vale do Sapucai
Intrauterine Device Placement
Intrauterine Device (IUD) Placement at the Time of Cesarean Section
To evaluate the continuation of the Copper IUD at one year after placement through the cesarean incision into the uterus at the time of cesarean section.
- Trial name
- NCT00986089
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Kentucky